肺癌放疗后心脏及其亚结构剂量学参数预测心脏事件或生存的系统综述与荟萃分析
该系统综述与荟萃分析纳入80项研究共21645例肺癌放疗患者,评估全心脏及心脏亚结构剂量参数与心脏事件及生存的关联。研究发现多个剂量学参数与主要不良心脏事件、心律失常、心包积液及生存显著相关,并识别出若干潜在预测阈值。
要点
- 左前降支V15与主要不良心脏事件显著相关,平均心脏剂量及心室、左前降支剂量与缺血事件显著相关。
- 平均心脏剂量、心脏V5/V35/V55及心包剂量与心包积液显著相关。
- 平均心脏剂量与生存显著相关,心脏基底剂量预测价值最显著。
核心结论
- 共识别130个全心脏及心脏亚结构剂量学参数与心脏事件相关,131个与生存结局相关,为放射诱导心脏损伤机制及保护干预策略提供依据。
研究设计与样本
- 遵循PRISMA指南的系统综述与荟萃分析,纳入80项研究共21645例肺癌放疗患者,采用JBI病例系列批判性评价清单评估偏倚风险。
- 结局分为主要不良心脏事件、心律失常、心包积液和生存,根据异质性采用随机或固定效应模型计算单变量和多变量分析的合并风险比。
主要发现
- 左前降支V15与主要不良心脏事件显著相关,平均心脏剂量及心室、左前降支剂量与缺血事件显著相关。
- 多个心脏亚结构参数与不同心律失常亚型相关。
- 平均心脏剂量、心脏V5/V35/V55及心包剂量与心包积液显著相关。
- 平均心脏剂量与生存显著相关,心脏亚结构参数也显示预测价值,中心脏基底剂量最显著。
关键数值与推荐
- 左前降支V15<10%对主要不良心脏事件有潜在预测价值。
- 左肺静脉V55<2%和右肺静脉V10<54%对心房颤动有潜在预测价值。
- 右心房V60<0.03 cc对非心房颤动性室上性心动过速有潜在预测价值。
- 左主干动脉V10≥1 cc对心动过缓性心律失常的潜在预测价值被识别。
临床怎么用
- 肺癌放疗计划评估中可关注心脏亚结构剂量参数,尤其是左前降支V15、平均心脏剂量及心脏基底剂量,以辅助预测心脏事件和生存风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The predictive value of radiation dose to the whole heart (WH) and cardiac substructures (CS) for cardiac events (CEs) and survival in patients with lung cancer remains uncertain. The goal of this study was to conduct a systematic review and meta-analysis to provide an evidence-based estimate of the relationship between these associations. A systematic meta-analysis was performed following PRISMA guidelines. Risk of bias was assessed using the JBI Critical Appraisal Checklist for Case Series. Outcomes were classified into major adverse cardiac events (MACE), arrhythmias, pericardial effusion, and survival. Depending on heterogeneity, random- or fixed-effects models were applied to calculate pooled hazard ratios (HRs) for univariable and multivariable analyses. A total of 80 studies, including 21,645 patients, were analyzed. Of these, 25 studies reported CEs, and 69 reported survival outcomes. Among 91 WH and 215 CS parameters evaluated, several showed significant associations. Key findings from our meta-analysis include: (1) left anterior descending (LAD) V15 was significantly associated with MACE. The mean heart dose (MHD), as well as ventricle and LAD doses, were significantly associated with ischemic events. (2) Multiple CS parameters were associated with different arrhythmia subtypes. (3) MHD, heart V5/V35/V55 and pericardial doses were significantly associated with pericardial effusion. (4) MHD was significantly associated with survival; CS parameters also showed predictive value, and especially, heart base dose being the most significant. (5) We also identified several thresholds with potential predictive values, such as LAD V15 <10% for MACE, left pulmonary vein (LPV) V55 <2%, and right pulmonary vein (RPV) V10 <54% for atrial fibrillation (AF), right atrium (RA) V60 <0.03 cc for non-AF supraventricular tachyarrhythmia, and left main artery (LMA) V10 ≥1 cc for bradyarrhythmia. This study identified 130 WH and CS dosimetric parameters associated with CEs and 131 with survival outcomes. These findings enhance our understanding of radiation-induced heart injury mechanisms and provide guidance for potential protective and intervention strategies.
引用
- Li X, Wu Y, Zhang Y, et al. Dosimetric Parameters of the Heart and Its Substructures in Predicting Cardiac Events or Survival in Patients With Lung Cancer After Radiation Therapy: A Systematic Review and Meta-analysis. Int J Radiat Oncol Biol Phys. 2026. PMID: 42288290. doi:10.1016/j.ijrobp.2026.05.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。